MedPath

A human study to evaluate safety and effectiveness of Pueraria Flos and Pericarpium Citri extract mixture on menopausal symptoms in postmenopausal wome

Not Applicable
Completed
Conditions
Endocrine, nutritional and metabolic disease
Registration Number
KCT0003335
Lead Sponsor
Ewha Womans University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
84
Inclusion Criteria

1) The particioants who give informed consent before the start
2) 45~60 years old
3) Postmenopause (defined as at least 12 months amenorrhoea) or Perimenopause (defined as having no more than one menstrual period during the 3 months before recruitment) women
4) Women with moderate to severe menopausal symptoms (Kupperman index total score = 15)
5) Women with an average of 10 or more daily hot flash score during the last week

Exclusion Criteria

1) Subjects with surgical or chemotherapy induced menopause, or who have been vaginal bleeding without diagnosis
2) Subjects who received hormone therapy within 6 months before the first visit
3) Subjects who consume a healthy functional food and herbal medicine that can affect menopausal health, bone health, blood sugar, blood lipids (triglyceride, cholesterol, etc.), blood pressure, blood circulation within 1 month of first visit
4) Subjects who have taken the following medication within the first month of their first visit or who need to take it during the study period.
5) Subjects with a history of breast cancer, endometrial hyperplasia, uterine endometrial cancer, sex steroid dependent organ tumors, or who have abnormal findings on breast X-ray or pelvic ultrasonography.
6) Subjects with liver disease, kidney disease, uncontrolled hypertension (SBP> 160 mmHg or DBP> 100 mmHg), thyroid disease, diabetes, hyperlipidemia, mental illness.
7) Subjects with a history of severe migraine headache, thromboembolic disorders, cerebrovascular disorders, serious cardiovascular condition within 1 year prior to the first visit or who need to take medicines as specified in the exclusion criteria.
8) Subjects with drug addicts or alcoholics
9) Subjects who performed constant exercises at least 3 months prior to the first visit
10) Subjects with hypersensitivity to components contained in the test food or test food
11) Subjects who participated in other clinical studies within 1 month prior to the first visit
12) Subjects who were deemed inappropriate to participation in this study

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Menopausal symptoms questionnaire (Kupperman Index, MENQOL)
Secondary Outcome Measures
NameTimeMethod
hot flash score;biochemical index;Safety index
© Copyright 2025. All Rights Reserved by MedPath